China Medical GatewayLoading your healthcare gateway…

Di Wei

Di Wei — Chief Physician — Urology — Renji Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine (East Campus)

Specialties

1. Kidney tumors: Robotic and laparoscopic minimally invasive treatment of kidney cancer, including robot-assisted laparoscopic partial nephrectomy, laparoscopic partial nephrectomy, laparoscopic radical nephrectomy for kidney cancer, zero-ischemia laparoscopic microwave ablation and enucleation of kidney tumors, open radical resection of large kidney cancer. Special expertise in robot-assisted minimally invasive nephron-sparing surgery for completely endophytic kidney tumors and hilar kidney tumors. 2. Ureteropelvic tumors: Laparoscopic radical nephroureterectomy for renal pelvis and ureteral tumors with lymph node dissection. Special expertise in transabdominal one-position semi-ureterectomy and retroperitoneal lymph node dissection. 3. Adrenal tumors: Laparoscopic minimally invasive treatment for functional and nonfunctional adrenal tumors, such as pheochromocytoma, primary hyperaldosteronism, Cushing's syndrome, adrenal myelolipoma, and adrenal cortical adenoma. Surgical removal of large adrenal tumors, such as adrenal cortical malignancies and adrenal metastases. 4. Comprehensive treatment of advanced metastatic kidney tumors and urothelial tumors, including neoadjuvant and adjuvant therapies involving targeted therapy, immunotherapy, chemotherapy, and others.

Education

Doctor of Medicine, Postdoctoral Fellow at University of Rochester Medical Center, USA

Professional Experience

Zhai Wei, Doctor of Medicine, Postdoctoral Fellow at the University of Rochester Medical Center in the United States, Chief Physician of Urology at Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Researcher, specializes in minimally invasive treatment of urinary system tumors, particularly in completely endogenous renal tumors, hilar tumors with robot-assisted minimally invasive nephron-sparing surgery, zero-ischemia laparoscopic microwave ablation and enucleation of renal tumors, transabdominal integrated partial urinary tract resection and retroperitoneal lymph node dissection, laparoscopic radical surgery and lymph node dissection for renal pelvis cancer and ureteral cancer, open surgery for large renal cancer and adrenal tumors, as well as comprehensive treatments such as targeted and immunotherapy for advanced renal cancer. He has been invited multiple times to perform live surgical demonstrations at various academic conferences in China.

Professional Roles

July 2022: Second phase of the "Cradle Program" Health Science Popularization Mentor at Shanghai Jiao Tong University School of Medicine July 2022: Director at Jing'an Changmu Program Health Promotion Center, Shanghai January 2022: Member of the Medical-Engineering Integration Branch of the Chinese Medical and Health Culture Association September 2021: Member of the Endoscopic Robot Branch of the Chinese Anti-Cancer Association July 2021: Member of the Translational Science Group of the Urology Physicians Branch of the Chinese Medical Doctor Association May 2021: Member of the Basic Science Group of the Urology Branch of the Chinese Medical Association November 2020: Young Committee Member of the first Sexual Medicine Professional Committee of the Shanghai Society of Integrative Chinese and Western Medicine November 2019: Academic Secretary of BJUI Chinese Edition May 2019: Member of the Chinese Society of Clinical Oncology (CSCO) April 2019: Member of the China TSC-AML Incubation Academy February 2019: External Review Expert of Minimally Invasive Urology January 2019: Young and Middle-aged Editorial Board Member and Reviewer of the Journal of Clinical and Pathology

Return to Home